A reversed-phase HPLC-based method for the assay of cyclic nucleotide phosphodiesterase activity

Analytical Biochemistry

Volumn 339, Issue 1, 2005, Pages 185-187

  Abbott, Belinda M ^a   Thompson, Philip E ^b,c  

^a MONASH UNIVERSITY   (Australia)

^b BOX HILL HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CYCLIC NUCLEOTIDE; PHOSPHODIESTERASE ACTIVITY; REVERSED PHASE HPLC;

NUCLEOTIDES;

ADENOSINE PHOSPHATE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;

ARTICLE; BIOASSAY; CELL TYPE; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYDROLYSIS; ION EXCHANGE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCINTILLATION;

EID: 14844292129     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.12.014     Document Type: Article

References (14)

1. M.J. Perry, and G.A. Higgs Chemotherapeutic potential of phosphodiesterase inhibitors Curr. Opin. Chem. Biol. 2 1998 472 481
2. W.J. Thompson, and M.M. Appleman Multiple cyclic nucleotide phosphodiesterase activities from rat brain Biochemistry 10 1971 311 316
3. Y. Qiu, S. Bhattacharjee, P. Kraft, T.M. John, E. Craig, D. Haynes-Johnson, J. Guan, W. Jiang, M. Macielag, Z. Sui, J. Clancy, and S. Lundeen Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859 Eur. J. Pharmacol. 472 2003 73 80
4. R.J. Schilling, D.R. Morgan, and B.F. Kilpatrick A high-throughput assay for cyclic nucleotide phosphodiesterase Anal. Biochem. 216 1994 154 158
5. L. Fawcett, R. Baxendale, P. Stacey, C. McGrouther, I. Harrow, S. Soderling, J. Hetman, J.A. Beavo, and S.C. Phillips Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11a Proc. Natl. Acad. Sci. USA 97 2000 3702 3707
6. C. Bardelle, C. Smales, M. Ito, K. Nomoto, E.Y.M. Wong, H. Kato, T. Saeki, and J.M. Staddon Phosphodiesterase 4 conformers: preparation of recombinant enzymes and assay for inhibitors Anal. Biochem. 275 1999 148 155
7. M.R. Nichols, and B.H. Morimoto Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins Mol. Pharmacol. 57 2000 738 745
8. S.R. Post, R.S. Ostrom, and P.A. Insel Biochemical methods for detection and measurement of cyclic AMP and adenylyl cyclase activity Methods Mol. Biol. 126 2000 363 374
9. A. Alfonso, M. Estevez, M.C. Louzao, M.R. Vieytes, and L.M. Botana Determination of phosphodiesterase activity in rat mast cells using the fluorescent cAMP analogue anthraniloyl cAMP Cell. Signal. 7 1995 513 518
10. G. Spoto, S. Berardi, G. Ajerba, and V. De Laurentiis A reverse-phase HPLC method for cyclic nucleotide phosphodiesterases activity and classification Adv. Exp. Med. Biol. 370 1994 815 820
11. T. Podzuweit, P. Nennstiel, and A. Muller Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3- nonyl) adenine Cell. Signal. 7 1995 733 738
12. S. Ogata, A. Suzuki, and T. Kawase A rapid quantitative analysis of intracellular nucleotides in osteoblasts using high-performance liquid chromatography Jpn. J. Oral Biol. 37 1995 1 8
13. B.M. Abbott, and P.E. Thompson PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues Bio-org. Med. Chem. Lett. 14 2004 2487 2851
14. T. Sudo, K. Tachibana, K. Toga, S. Tochizawa, Y. Inoue, Y. Kimura, and H. Hidaka Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity Biochem. Pharmacol. 59 2000 347 356